Compounds > ly 293558
Page last updated: 2024-09-03

ly 293558 and Ischemic Attack, Transient

ly 293558 has been researched along with Ischemic Attack, Transient in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gill, R; Lodge, D1
Bowes, MP; Swanson, S; Zivin, JA1

Other Studies

2 other study(ies) available for ly 293558 and Ischemic Attack, Transient

ArticleYear
The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia.
    Neuropharmacology, 1994, Volume: 33, Issue:12

    Topics: Analysis of Variance; Animals; Ischemic Attack, Transient; Isoquinolines; Male; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tetrazoles

1994
The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1996, Volume: 16, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Ischemia; Ischemic Attack, Transient; Isoquinolines; Kinetics; Male; Paraplegia; Rabbits; Reperfusion Injury; Spinal Cord; Tetrazoles

1996